🔗 Share this article

Chancellor Rachel Reeves has announced she is planning "focused steps to deal with cost of living challenges" in next month's financial statement.

In comments to the BBC, she noted that reducing price rises is a joint responsibility of both the government and the Bank of England.

The United Kingdom's inflation rate is expected to be the most elevated among the Group of Seven industrialized countries this calendar year and the following year.

Potential Energy Cost Interventions

Reports indicate the government could intervene to reduce energy bills, for instance by slashing the current 5% level of VAT charged on energy supplies.

A further approach is to lower some of the regulatory levies currently added to bills.

Budgetary Constraints and Expert Expectations

The administration will receive the latest assessment from the official forecaster, the Office for Budget Responsibility, on Monday, which will clarify how much scope there is for these actions.

The consensus from most experts is that the Chancellor will have to announce tax increases or budget cuts in order to meet her declared fiscal targets.

Previously on the same day, calculations showed there was a £22bn deficit for the Treasury chief to address, which is at the more modest range of projections.

"It is a joint job between the central bank and the administration to continue tackling some of the sources of price increases," the Chancellor informed reporters in the US capital, at the conferences of the International Monetary Fund and World Bank.

Tax Commitments and International Issues

While a great deal of the focus has been on probable tax increases, the chancellor said the most recent information from the fiscal watchdog had not changed her vow to manifesto promises not to increase tax levels on income tax, VAT or social security contributions.

She blamed an "unpredictable world" with rising international and trade issues for the Budget tax moves, probably to be targeted on those "with the broadest shoulders."

Global Economic Tensions

Addressing concerns about the UK's commercial links with the Asian nation she said: "Our national security invariably come first."

Last week's announcement by Chinese authorities to strengthen trade restrictions on critical minerals and other resources that are essential for advanced tech production led US President the US President to suggest an further 100% tariff on goods from China, raising the possibility of an full-scale commercial conflict between the two global powers.

The American finance chief called China's action "economic coercion" and "a international production control attempt."

Asked about considering the American proposal to join its dispute with China, Reeves said she was "extremely troubled" by Chinese actions and encouraged the Chinese government "to avoid restrictions and restrict access."

She said the move was "harmful for the international commerce and causes additional challenges."

"I believe there are areas where we must confront China, but there are also important chances to sell into Chinese markets, including financial services and other sectors of the economy. We've got to get that balance appropriate."

The chancellor also affirmed she was cooperating with G7 counterparts "regarding our own critical minerals strategy, so that we are less reliant."

NHS Medicine Pricing and Funding

The Chancellor also acknowledged that the cost the National Health Service pays for medicines could increase as a consequence of ongoing negotiations with the Trump administration and its pharmaceutical firms, in exchange for lower tariffs and investment.

Some of the biggest global drug companies have said in recent statements that they are either pausing or scrapping investments in the United Kingdom, with some attributing the modest returns they are getting.

Last month, the Science Minister said the cost the NHS spends on drugs would must increase to halt firms and drug research funding departing from the UK.

The Chancellor informed media: "We have seen because of the cost structure, that clinical trials, new drugs have not been provided in the United Kingdom in the way that they are in other continental states."

"The objective is to ensure that individuals getting care from the National Health Service are can obtain the finest critical drugs in the globe. And so we are reviewing these issues, and... looking to attract more investment into the UK."